Synonyms: XF-73 (exeporfinium chloride)
Compound class:
Synthetic organic
Comment: Exeporfinium is a novel dicationic porphyrin antibacterial compound with activity against a wide range of Gram-positive bacteria, including Staphylococcus aureus [2,4]. We show the structure of the parent molecule here. The INN represents the chloride salt form (XF-73, CAS number 718638-68-7) and this is also the form that is under clinical evaluation.
|
|
References |
1. Farrell DJ, Robbins M, Rhys-Williams W, Love WG. (2010)
In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species. Int J Antimicrob Agents, 35 (6): 531-6. [PMID:20346634] |
2. Maisch T, Bosl C, Szeimies RM, Lehn N, Abels C. (2005)
Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob Agents Chemother, 49 (4): 1542-52. [PMID:15793136] |
3. Mangino JE, Firstenberg MS, Milewski RKC, Rhys-Williams W, Lees JP, Dane A, Love WG, Gonzalez Moreno J. (2023)
Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study. Infect Control Hosp Epidemiol, 44 (7): 1171-1173. [PMID:36951472] |
4. Ooi N, Miller K, Hobbs J, Rhys-Williams W, Love W, Chopra I. (2009)
XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity. J Antimicrob Chemother, 64 (4): 735-40. [PMID:19689976] |
5. Ooi N, Miller K, Randall C, Rhys-Williams W, Love W, Chopra I. (2010)
XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms. J Antimicrob Chemother, 65 (1): 72-8. [PMID:19889790] |